Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 63 results for neuropathic pain

  1. Carbamazepine for treating trigeminal neuralgia:- What is the clinical and cost effectiveness of carbamazepine as initial treatment for trigeminal neuralgia compared with other pharmacological treatments?

    guidance. Source guidance details Comes from guidance Neuropathic pain in adults: pharmacological management in non-specialist settings

    Research recommendation
    Published
    9 June 2015

  2. NICE encourages further research into percutaneous electrical nerve stimulation (PENS) for refractory neuropathic pain, particularly to provide more information about selection criteria and long-term outcomes, with clear documentation of the indications for treatment.

    into percutaneous electrical nerve stimulation (PENS) for refractory neuropathic pain, particularly to provide more information about...

    Research recommendation
    Published
    9 June 2015

  3. Factors affecting participation and quality of life:- What are the key factors, including additional care and support, that influence participation and quality of life in people with neuropathic pain?

    support, that influence participation and quality of life in people with neuropathic pain? Any explanatory notes(if applicable) Why this...

    Research recommendation
    Published
    9 June 2015

  4. Impact of drug-related adverse effects on cost effectiveness and quality of life:- What is the impact of drug-related adverse effects on health economics and quality of life in neuropathic pain?

    of life in neuropathic pain? Any explanatory notes(if applicable) Why this is important:- Pharmacological agents for neuropathic...

    Research recommendation
    Published
    9 June 2015

  5. Relationship between symptoms, cause of neuropathic pain and its treatment:- Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom characteristics?

    CG173/2 Question Relationship between symptoms, cause of neuropathic pain and its treatment:- Is response to pharmacological treatment...

    Research recommendation
    Published
    9 June 2015

  6. Potential for dependence associated with pharmacological drugs for neuropathic pain:- Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    pharmacological drugs for neuropathic pain:- Is there a potential for dependence associated with pharmacological agents for...

    Research recommendation
    Published
    9 June 2015

  7. Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness and tolerability of pharmacological monotherapy compared with combination therapy for treating neuropathic pain?

    Question Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness...

    Research recommendation
    Published
    9 June 2015

  8. Percutaneous electrical nerve stimulation for refractory neuropathic pain (HTG308)

    Evidence-based recommendations on percutaneous electrical nerve stimulation for refractory neuropathic pain. This involves inserting electrode needles underneath the skin connected to a stimulator device.

    HealthTech guidance
    Published
    27 March 2013
    View recommendations

    Sections for HTG308

  9. Deep brain stimulation for refractory chronic pain syndromes (excluding headache) (HTG253)

    Evidence-based recommendations on deep brain stimulation for refractory chronic pain syndromes (excluding headache). This involves stimulating a precise area of the brain using an electrode to treat the chronic pain.

    HealthTech guidance
    Published
    23 March 2011
    View recommendations

    Sections for HTG253

  10. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin (TA159)

    Evidence-based recommendations on spinal cord stimulation for chronic pain of neuropathic or ischaemic origin in adults.

    Technology appraisal guidance
    Published
    22 October 2008
    View recommendations

    Sections for TA159

  11. Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain (HTG150)

    Evidence-based recommendations on laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain. This involves the destruction of a small segment of ligament that carries nerve fibres within the pelvis.

    HealthTech guidance
    Published
    30 October 2007
    View recommendations

    Sections for HTG150

  12. Chronic and neuropathic pain

    All NICE products on chronic and neuropathic pain. Includes any guidance, advice and quality standards.

    Topic page

  13. GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain

    In development Reference number: GID-MT567 Expected publication date: TBC

    Medical technologies guidance
    In development

  14. Low-level laser therapy (photobiomodulation) for oral neuropathic pain

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  15. Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (MTG41)

    We have moved Medical technologies guidance 41 to become HealthTech guidance 498. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance